PMID- 1371050 OWN - NLM STAT- MEDLINE DCOM- 19920311 LR - 20190501 IS - 0264-6021 (Print) IS - 1470-8728 (Electronic) IS - 0264-6021 (Linking) VI - 281 ( Pt 2) IP - Pt 2 DP - 1992 Jan 15 TI - Binding of transforming growth factor-beta 1 to methylamine-modified alpha 2-macroglobulin and to binary and ternary alpha 2-macroglobulin-proteinase complexes. PG - 569-75 AB - The binding of 125I-labelled transforming growth factor-beta 1 (TGF-beta 1) to human alpha 2-macroglobulin (alpha 2M) was studied by native PAGE and autoradiography. TGF-beta 1 bound preferentially to alpha 2M-methylamine and minimally, if at all, to native alpha 2M. Preparations of alpha 2M-proteinase complex were generated by incubating a standard concentration of alpha 2M (0.4 microM) with different concentrations of trypsin, chymotrypsin or neutrophil elastase (0.04-2.0 microM). The 125I-TGF-beta 1-binding activity depended on the initial ratio of active proteinase to alpha 2M, or r value, used to form the alpha 2M-proteinase complex. With all three proteinases, r values of 2 or greater yielded preparations with unchanged or decreased TGF-beta 1-binding activity relative to native alpha 2M. By contrast, r values near 1 yielded preparations with significantly increased TGF-beta 1-binding activity. The results of [3H]thymidine-incorporation studies performed in mouse keratinocytes were consistent with the 125I-TGF-beta-binding experiments. alpha 2M-trypsin and alpha 2M-chymotrypsin prepared at an r value of 1.0 counteracted the activity of TGF-beta 1, whereas the equivalent complexes prepared at an r value of 3.0 had no effect. As determined by SDS/PAGE, 125I-TGF-beta 1 binding to alpha 2M-methylamine was at least 80% non-covalent. Reaction of alpha 2M-methylamine with iodoacetamide or 5,5'-dithiobis-(2-nitrobenzoic acid) decreased the percentage of covalent binding but had no effect on total binding. Neuraminidase treatment had no effect on the binding of 125I-TGF-beta 1 to alpha 2M-methylamine. Cleavage of the 'bait regions' in alpha 2M-methylamine by prolonged treatment with trypsin also had no effect. These studies suggest that TGF-beta 1 binding to alpha 2M is enhanced by conformational change in the proteinase inhibitor resulting from reaction with proteinase or amine. If both proteinase-binding sites in a single alpha 2M molecule are occupied, TGF-beta 1-binding activity is decreased or perhaps eliminated. FAU - Hall, S W AU - Hall SW AD - Department of Pathology, University of Virginia Health Sciences Center, Charlottesville 22908. FAU - LaMarre, J AU - LaMarre J FAU - Marshall, L B AU - Marshall LB FAU - Hayes, M A AU - Hayes MA FAU - Gonias, S L AU - Gonias SL LA - eng GR - GM 07267/GM/NIGMS NIH HHS/United States GR - HL-02272/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. PL - England TA - Biochem J JT - The Biochemical journal JID - 2984726R RN - 0 (Methylamines) RN - 0 (Transforming Growth Factor beta) RN - 0 (alpha-Macroglobulins) RN - EC 3.2.1.18 (Neuraminidase) RN - EC 3.4.- (Endopeptidases) RN - EC 3.4.21.1 (Chymotrypsin) RN - EC 3.4.21.36 (Pancreatic Elastase) RN - EC 3.4.21.4 (Trypsin) SB - IM MH - Animals MH - Cells, Cultured MH - Chymotrypsin/metabolism MH - Electrophoresis, Polyacrylamide Gel MH - Endopeptidases/*metabolism MH - Humans MH - Keratinocytes/metabolism MH - Methylamines/pharmacology MH - Mice MH - Mice, Inbred BALB C MH - Neuraminidase/metabolism MH - Pancreatic Elastase/metabolism MH - Transforming Growth Factor beta/antagonists & inhibitors/*metabolism MH - Trypsin/metabolism MH - alpha-Macroglobulins/chemistry/*metabolism PMC - PMC1130723 EDAT- 1992/01/15 00:00 MHDA- 1992/01/15 00:01 PMCR- 1992/01/15 CRDT- 1992/01/15 00:00 PHST- 1992/01/15 00:00 [pubmed] PHST- 1992/01/15 00:01 [medline] PHST- 1992/01/15 00:00 [entrez] PHST- 1992/01/15 00:00 [pmc-release] AID - 10.1042/bj2810569 [doi] PST - ppublish SO - Biochem J. 1992 Jan 15;281 ( Pt 2)(Pt 2):569-75. doi: 10.1042/bj2810569.